Skip to main content
Premium Trial:

Request an Annual Quote

Linux Networx, NSF and NIH, Pyrosequencing


Boehringer Opts for Linux Networx Cluster

Linux Networx of Salt Lake City said last week that Boehringer Ingelheim Pharmaceuticals is installing a 120-processor Linux NetworX Evolocity cluster in its Ridgefield, Conn., laboratory.

Dave Craska, lead systems engineer for Boehringer Ingelheim Pharmaceuticals, said the software provided by Linux Networx as part of the installation, “helps alleviate the complexities of cluster management, especially when upgrading and propagating new releases of software.”

The company’s Evolocity system includes 120 Pentium III 866 MHz processors, 50 GB of memory, an Intel 10/100 NIC connection and ClusterWorX cluster management software.

 NIH, NSF Offer Bioinformatics Summer School

The NSF and NIH are collaborating on a joint program to help train tomorrow’s bioinformaticists. The NIH-NSF Bioengineering and Bioinformatics Summer Institutes Program (BBSI), announced last week, will support “Summer Institutes” for students majoring in the biological sciences, computer sciences, engineering, mathematics, and physical sciences.

BBSI will offer “interdisciplinary bioengineering or bioinformatics research and education experiences,” according to the program description, available at

 Pyrosequencing Puts XML to Work

With the recent release of its PSQ 96MA sequence analysis system, Pyrosequencing of Uppsala, Sweden, has also debuted a new XML format it developed for data handling. The format, PDEX (Pyrosequencing Data Exchange), is based on the standard XML format and will be available for Pyrosequencing customers at its web site ( this month.

According to the company, the format speeds data import and export for its SNP and sequence analysis software. PDEX documents can be transformed into other XML formats or other text-based formats such as tab-delimited or FASTA. They can also be transformed to HTML for presentation in web browsers, the company said.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.